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The human multidrug resistance protein 3 (MDR3/
ABCB4) belongs to the ATP binding cassette (ABC)
transporter family found in all kingdoms of life. MDR3 is
located in the canalicular membrane of hepatocytes and
translocates phosphatidylcholine (PC) from the inner to
the outer leaflet of the canalicular membrane energized
by ATP hydrolysis. PC is one major component of bile
and is essential to protect the biliary duct from bile salts,
which are translocated by the bile salt export pump
(BSEP/ABCB11). Phosphatidylcholine, bile salts and cho-
lesterol translocated by ABCG5/G8 form mixed micelles.
These mixed micelles have a lower capacity to extract
lipids from the membrane and prevent the crystallization
of cholesterol in the biliary duct. Different types of liver
diseases e.g. progressive familial intrahepatic cholestasis
type 3 (PFIC 3) are caused by dysfunction of MDR3. On
the one hand mutations within the MDR3 gene can abol-
ish the ATPase activity and PC lipid transport, respec-
tively. On the other hand defects of the regulation
pathway with respect to the targeting and retention
of MDR3 to the canliculare membrane can occur.
Currently, it is not known, how MDR3 is regulated and
targeted to the canalicular membrane. Further, MDR3
shares over 75 % identity with the multidrug resistance
protein 1 (MDR1/ABCB1). MDR1 is well-characterized
and plays an enormous challenge in chemotherapy. If
we identify the regulation mechanism of MDR3, we
will as well contribute to the understanding of MDR1
regulation.
Several adaptor proteins are identified, which are impor-
tant for the incorporation, retention and degradation of
ABC transporters into the canalicular membrane of hepa-
tocytes. For example, the adaptor protein NHERF-1 is cru-
cial for the internalization of MRP2 and MRP4, Radixin
(RDX) for MRP2 and HAX-1 for BSEP. NHERF-1 con-
tains two PDZ domains, which binds amongst others the
highly conserved motive (S/T)X(V/I/L/A/F/M) (X = any
amino acid). The primary sequence of the second MDR3
nucleotide binding domain (NBD) contains several times
this binding motive. This is a first hint that NHERF-1
binds also MDR3. RDX is a member of the Ezrin/Radixin/
Moesin (ERM) protein family and is mainly localized at
the canalicular membrane of hepatocytes. The N-termi-
nale FERM (4.1-protein, Erzin, Radixin, Moesin) domain
of RDX binds the C-terminus of MRP2. The amino acid
sequence alignment of MRP2 and MDR3 showed no con-
served amino acids at the C-terminus.
Ikebuchi Y. et al. used a yeast-two hybrid screen with a
cytoplasmatic linker region of MDR3 and a human liver
cDNA library to identify interaction proteins of MDR3.
They determined that the localization of MDR3 is regu-
lated by the receptor for activated C-kinase 1 (RACK1)
[1]. We used RACK1 as an internal control for our
experiments.
To understand how MDR3 is targeted to the apical
membrane, we aimed to identify further interaction part-
ners of this transporter. For this purpose we want to use
in vitro pulldown assays, size exclusion chromatography
and blue native page with purified MDR3 and the poten-
tially interaction proteins. First, we cloned the human
cDNA of MDR3 in Saccharomyces cerevisiae and expressed
MDR3 in the methylotrophic yeast Pichia pastoris in
amounts suitable for a detailed structure-function analysis.
We tested over 100 different detergents via dotblot analysis
and found that only lipid-like detergents as Fos-cholines
(FCs) were able to extract MDR3 in adequate yields.
MDR3 was purified with FC-16 via tandem-affinity purifi-
cation (TAP) consisting of an immobilized metal ion
affinity chromatography and a calmodulin binding peptide
purification step. About 6 mg protein per 100 g wet cells
were obtained with high purity and homogeneity. The
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functionality was determined by measuring the ATPase
activity of purified MDR3 in detergent solution. Purified
MDR3 exhibited significant ATP hydrolysis activity that
could be stimulated by DPPC and DOPC. To eliminate any
possibility of unspecific ATPase activity due to contami-
nants, we cloned and purified an ATPase inactive mutant,
where the glutamic acid is changed to a glutamine in the
highly conserved Walker B motive of both NBDs. This
mutant (E558Q/E1027Q) showed basal ATPase activity
comparable to the wild-type protein. But more important,
no ATPase activity stimulation by adding PC lipids to the
reaction was obtained. So far our work demonstrates that
heterologously expressed MDR3 can be purified in a func-
tional state with respect to its capability to bind and hydro-
lyze ATP [2].
Second, we cloned the cDNA of the adaptor proteins
NHERF-1 and RDX combined with a StrepII affinity tag in
the Escherichia coli expression system. RACK1 cDNA was
fused to a hexa-histidine affinity tag and expressed also in
E. coli. Recently, we purified the interaction proteins
NHERF-1 and RDX with Strep-tactin sepharose to high
purity and homogenity. RACK1 was purified via immobi-
lized metal ion affinity purification and size exclusion
chromatography. We obtained approximately 20 mg out
of 2 L cell culture.
To determine the interaction of MDR3 with the puta-
tive interaction partners NHERF-1, RDX and RACK1 we
want to use the in vitro pull-down assay, size exclusion
chromatography (SEC) and blue native page. For the
pull-down assay, the purified interaction partner was
mixed with the purified and functional MDR3. Then one
of the proteins was immobilized on the corresponding
matrix by the affinity tag. After several washing steps, the
complex was eluted and identified via immunoblotting.
Currently, we have done initial pull-down assays with
MDR3 and the positive control RACK1. MDR3 was
immobilized by the calmodulin binding peptide (CBP) to
calmodulin resin and eluted after adding EGTA. RACK1
has a size of 35 kDA and is obtained at the 35 kDA mar-
ker band in the SDS-PAGE gel. It binds unspecifically to
the CBP resin. In the immunoblot against RACK1 we
determined in the reaction of MDR3 and RACK1 an
additional band of about 130 kDA for RACK1, while
RACK1 alone ran at 35 kDa. One explanation is that
RACK1 forms a highly stable complex with MDR3,
which is resistent against SDS. To confirm this result we
tried blue native page, but unfortunately we did not suc-
ceed so far. With this first results we can verify that
MDR3 interacts with RACK1. Further, we want to ana-
lyze NHERF-1 and RDX concerning the potential inter-
action with MDR3.
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